Wellington Hospital

Newtown, Wellington Region 6021

2 studies enrolling now · 13 studies all time

What they study most

Acute Renal Failure, Blood Loss, Surgical, Catecholamine-resistant Hypotension (CRH), Coagulation Disorder, Colorectal Cancer Metastatic, Coronary Artery Disease, Critical Limb Ischemia, Crohn's Disease, Distributive Shock, Fallopian Tube Cancer, HIV Infections, High Output Shock

Studies at this site

• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin. — Starting soon
• Prevention of Serious Adverse Events Following Angiography — Completed
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) — Completed
• Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) — Completed
• Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia — Completed
• Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) — Stopped early
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis — Completed
• Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306) — Stopped early
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis — Stopped early
• FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer — Completed
• A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension — Completed
• Collection of Blood Samples From SMART Study Participants for Future Genetic Studies — Completed